EBOLA vaccine

The Republic of Guinea has commenced vaccination of volunteers with a Russian-made Ebola drug.

The first batch of the Russian-made Ebola vaccine was delivered to the Republic of Guinea.

FSBI National Research Center for Epidemiology and Microbiology named after the honorary academician N. F. Gamaleya of the Russian Ministry of Health has developed a full volume of an Ebola vaccine.

FSBI National Research Center for Epidemiology and Microbiology named after the honorary academician N. F. Gamaleya of the Russian Ministry of Health has developed a full volume of an Ebola vaccine.

A delegation of Russian scientists took part in the proceedings of the 69th session of the World Health Assembly in Geneva “Russia’s Ebola vaccine: prospects for joint action”.

The National Ethics Committee under the Ministry of Health of the Republic of Guinea is completing the approval procedure for a project for the use of the Ebola vaccine in Guinea, developed by FSBI National Research Center for Epidemiology and Microbiology named after the honorary academician N. F. Gamaleya of the Russian Ministry of Health.

Russia’s Ebola vaccine is ready for post-clinical trials in Guinea.

Russia’s Minister of Health V.  I. Skvortsova took part in the round table "Russia’s Ebola vaccine: first lessons and looking into the future".

A presentation about Russia’s Ebola vaccine was held in Geneva.

Russia’s Minister of Health V.  I. Skvortsova visited FSBI National Research Center for Epidemiology and Microbiology named after the honorary academician N. F. Gamaleya of the Russian Ministry of Health, where a presentation of the Ebola vaccine developed by domestic scientists was held.